184 related articles for article (PubMed ID: 20701838)
1. Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.
Dille MF; Konrad-Martin D; Gallun F; Helt WJ; Gordon JS; Reavis KM; Bratt GW; Fausti SA
J Am Acad Audiol; 2010 Jun; 21(6):409-17. PubMed ID: 20701838
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
Frisina RD; Wheeler HE; Fossa SD; Kerns SL; Fung C; Sesso HD; Monahan PO; Feldman DR; Hamilton R; Vaughn DJ; Beard CJ; Budnick A; Johnson EM; Ardeshir-Rouhani-Fard S; Einhorn LH; Lipshultz SE; Dolan ME; Travis LB
J Clin Oncol; 2016 Aug; 34(23):2712-20. PubMed ID: 27354478
[TBL] [Abstract][Full Text] [Related]
4. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
Dillard LK; Lopez-Perez L; Martinez RX; Fullerton AM; Chadha S; McMahon CM
Cancer Epidemiol; 2022 Aug; 79():102203. PubMed ID: 35724557
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
Plaut ME; Schentag JJ; Jusko WJ
J Med; 1979; 10(4):257-66. PubMed ID: 294466
[TBL] [Abstract][Full Text] [Related]
6. Neurochemistry of the peripheral and central auditory system after ototoxic drug exposure: implications for tinnitus.
Rybak LP
Int Tinnitus J; 2005; 11(1):23-30. PubMed ID: 16419684
[TBL] [Abstract][Full Text] [Related]
7. Sound preconditioning therapy inhibits ototoxic hearing loss in mice.
Roy S; Ryals MM; Van den Bruele AB; Fitzgerald TS; Cunningham LL
J Clin Invest; 2013 Nov; 123(11):4945-9. PubMed ID: 24216513
[TBL] [Abstract][Full Text] [Related]
8. Recovery from vestibular ototoxicity.
Black FO; Gianna-Poulin C; Pesznecker SC
Otol Neurotol; 2001 Sep; 22(5):662-71. PubMed ID: 11568676
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside toxicity in infants and children.
McCracken GH
Am J Med; 1986 Jun; 80(6B):172-8. PubMed ID: 3524215
[TBL] [Abstract][Full Text] [Related]
10. [Comparative ototoxicity of aminoglycoside antibiotics in a guinea pig model (author's transl)].
Brummett RE
Nouv Presse Med; 1978 Nov; 7(42):3849-53. PubMed ID: 568779
[TBL] [Abstract][Full Text] [Related]
11. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
Waissbluth S; Del Valle Á; Chuang A; Becker A
Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
[TBL] [Abstract][Full Text] [Related]
13. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
Ogier JM; Lockhart PJ; Burt RA
Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.
El Charif O; Mapes B; Trendowski MR; Wheeler HE; Wing C; Dinh PC; Frisina RD; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Mushiroda T; Kubo M; Gamazon ER; Cox NJ; Huddart R; Ardeshir-Rouhani-Fard S; Monahan P; Fossa SD; Einhorn LH; Travis LB; Dolan ME
Clin Cancer Res; 2019 Jul; 25(13):4104-4116. PubMed ID: 30952644
[TBL] [Abstract][Full Text] [Related]
15. Prevention of noise- and drug-induced hearing loss with D-methionine.
Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
[TBL] [Abstract][Full Text] [Related]
16. Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss.
Vanoverschelde A; Oosterloo BC; Ly NF; Ikram MA; Goedegebure A; Stricker BH; Lahousse L
J Antimicrob Chemother; 2021 Sep; 76(10):2708-2716. PubMed ID: 34312676
[TBL] [Abstract][Full Text] [Related]
17. Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.
Ruhl D; Du TT; Wagner EL; Choi JH; Li S; Reed R; Kim K; Freeman M; Hashisaki G; Lukens JR; Shin JB
J Neurosci; 2019 Apr; 39(15):2951-2964. PubMed ID: 30733218
[TBL] [Abstract][Full Text] [Related]
18. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
De Broe ME; Giuliano RA; Verpooten GA
Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
[TBL] [Abstract][Full Text] [Related]
19. [Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics].
Lautermann J; Dehne N; Schacht J; Jahnke K
Laryngorhinootologie; 2004 May; 83(5):317-23. PubMed ID: 15143449
[TBL] [Abstract][Full Text] [Related]
20. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
Reavis KM; McMillan G; Austin D; Gallun F; Fausti SA; Gordon JS; Helt WJ; Konrad-Martin D
Ear Hear; 2011 Feb; 32(1):61-74. PubMed ID: 20625302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
